Read More Healthcare Industry News Medtronic stock dips even as FDA clears Altaviva device for bladder control breakthrough Medtronic (NYSE: MDT) wins FDA approval for Altaviva, a minimally invasive bladder control device. Find out why the stock fell and what it means for investors. byPallavi MadhirajuSeptember 19, 2025